What is the ticker symbol for Arbutus Biopharma Corp?

Arbutus Biopharma Corp trades under the ticker ABUS on NASDAQ.

What sector does Arbutus Biopharma Corp operate in?

Arbutus Biopharma Corp is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ABUS in a portfolio?

PortView shows ABUS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Arbutus Biopharma Corp (ABUS) Stock Analysis

NASDAQHealthcareBiotechnology

$5.11+0.39%

1-year price historyRange $3.67 – $5.22

52-week range$5.11

$3.50$5.45

What Arbutus Biopharma Corp does

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients’ HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.

Key metrics

Market cap

$1.01B

P/E (TTM)

6.16

EPS (TTM)

$0.83

Beta

0.60

Dividend yield

0.00%

Revenue / share

$0.92

50-day avg

$4.71

200-day avg

$4.48

52-week high

$5.45

52-week low

$3.50

CEO

Lindsay Androski

ETFs linked to ABUS

Broad-market and Healthcare sector ETFs an investor holding Arbutus Biopharma Corp is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ABUS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ABUS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Arbutus Biopharma Corp?: Arbutus Biopharma Corp trades under the ticker ABUS on NASDAQ.
Which exchange is ABUS listed on?: ABUS is listed on NASDAQ.
What sector does Arbutus Biopharma Corp operate in?: Arbutus Biopharma Corp is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ABUS in a portfolio?: PortView shows ABUS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.